Restrospective Study of Outcomes of Patients with WHO Groups 1 and 3 Pulmonary Hypertension Treated with High-Dose Inhaled Treprostinil

Administered By

Awarded By

Contributors

Start/End

  • February 28, 2018 - January 31, 2019